Pioneering clinical trial to treat psychosis in Parkinson’s patients using cannabidiol
A pioneering clinical trial will investigate the use of cannabidiol (CBD) - a compound found in the cannabis plant - in people with...
UK charity announces research investment to find Parkinson’s drug
“This is an exciting new approach that could rescue defective mitochondria inside neurons to prevent dysfunction and degeneration of dopamin
Charity invests £1 million to develop a treatment to slow down progression of Parkinson’s
Parkinson’s UK have partnered with NRG Therapeutics to find a drug that could protect dopamine cells damaged by the condition Charity...
FDA approves Neurolixis IND application for clinical trial with NLX-112 in Parkinson’s disease
The US Food and Drug Administration (FDA) gave a positive response to Neurolixis’ Investigational New Drug (IND) application for NLX-112....
Pioneering trial offers hope for restoring brain cells damaged in Parkinson’s
Results from a pioneering clinical trials programme that delivered an experimental treatment directly to the brain offer hope that it may...
Parkinson’s UK invests further £1.5million to develop novel gene transcription modulators
Parkinson’s UK has today announced that it is investing a further £1.5million to advance its exciting drug discovery programme to develop...